Market Cap ₹10 Cr.
Stock P/E 0.1
P/B 0.8
Current Price ₹5
Book Value ₹ 6.4
Face Value 5
52W High ₹5
Dividend Yield 0%
52W Low ₹ 1.8
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 4 | 2 | 2 | 2 | 2 | 2 | 4 | 2 | 6 | 2 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 1 |
Total Income | 4 | 2 | 2 | 2 | 2 | 2 | 4 | 2 | 6 | 3 |
Total Expenditure | 5 | 3 | 3 | 3 | 3 | 3 | 7 | 4 | 7 | 7 |
Operating Profit | -1 | -0 | -1 | -1 | -1 | -2 | -3 | -1 | -1 | -4 |
Interest | 0 | 0 | 10 | 3 | 3 | 3 | 3 | 3 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 4 | 0 | -3 | 0 | 0 | 0 | 0 | 0 | 65 | 0 |
Profit Before Tax | 3 | -0 | -14 | -4 | -4 | -4 | -6 | -4 | 64 | -4 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 3 | -0 | -14 | -4 | -4 | -4 | -6 | -4 | 64 | -4 |
Adjustments | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 3 | -0 | -14 | -4 | -4 | -4 | -6 | -4 | 64 | -4 |
Adjusted Earnings Per Share | 1.7 | -0 | -7.3 | -1.9 | -2 | -2.3 | -3 | -3.5 | 51.5 | -3.3 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|
Net Sales | 18 | 18 | 12 | 9 | 10 | 14 |
Other Income | 1 | 1 | 1 | 1 | 1 | 1 |
Total Income | 19 | 18 | 12 | 10 | 10 | 15 |
Total Expenditure | 21 | 20 | 13 | 13 | 16 | 25 |
Operating Profit | -2 | -2 | -1 | -3 | -6 | -9 |
Interest | 0 | 0 | 0 | 10 | 11 | 6 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 3 | -5 | 0 | 2 | -2 | 65 |
Profit Before Tax | 1 | -7 | -1 | -11 | -20 | 50 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 1 | -7 | -1 | -11 | -20 | 50 |
Adjustments | 1 | -0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 1 | -7 | -1 | -11 | -20 | 50 |
Adjusted Earnings Per Share | 0.6 | -3.8 | -0.4 | -5.8 | -10.3 | 41.7 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 11% | -18% | 0% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 0% | 0% | 0% | 0% |
ROCE Average | -101% | -34% | -20% | -20% |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Shareholder's Funds | 13 | 6 | 5 | -28 | -48 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 |
Borrowings | 13 | 13 | 13 | 63 | 73 |
Other Non-Current Liabilities | -8 | -8 | -8 | -8 | -8 |
Total Current Liabilities | 56 | 44 | 45 | 11 | 23 |
Total Liabilities | 74 | 55 | 56 | 39 | 40 |
Fixed Assets | 59 | 42 | 42 | 27 | 28 |
Other Non-Current Assets | 3 | 1 | 2 | 1 | 1 |
Total Current Assets | 12 | 12 | 12 | 10 | 12 |
Total Assets | 74 | 55 | 56 | 39 | 40 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | 1 | -26 | 1 | -22 | 1 |
Cash Flow from Investing Activities | -0 | 24 | 0 | 4 | -0 |
Cash Flow from Financing Activities | -1 | 2 | -1 | 18 | -1 |
Net Cash Inflow / Outflow | -0 | -0 | -0 | -0 | 0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 |
# | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.61 | -3.77 | -0.36 | -5.75 | -10.35 |
CEPS(Rs) | 0.57 | -3.58 | -0.31 | -5.69 | -10.29 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | -17.9 | -14.6 | -14.9 | -25.78 | -36.2 |
Core EBITDA Margin(%) | -14.46 | -14.86 | -9.46 | -38.36 | -70.26 |
EBIT Margin(%) | 3.36 | -39.9 | -5.54 | -12.47 | -87.78 |
Pre Tax Margin(%) | 3.33 | -39.96 | -5.74 | -115.49 | -206.46 |
PAT Margin (%) | 3.33 | -39.96 | -5.74 | -116.21 | -206.46 |
Cash Profit Margin (%) | 5.9 | -38.85 | -4.94 | -115.07 | -205.28 |
ROA(%) | 0.82 | -10.86 | -1.23 | -23.3 | -50.17 |
ROE(%) | 0 | 0 | 0 | 0 | 0 |
ROCE(%) | 0 | 0 | 0 | 0 | -100.5 |
Receivable days | 99.48 | 112.72 | 167.22 | 139.86 | 94.66 |
Inventory Days | 34.39 | 31.92 | 43.72 | 71.66 | 74.35 |
Payable days | 319.08 | 255.53 | 283.99 | 244.07 | 127.35 |
PER(x) | 0 | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.2 | 1.26 | 1.88 | 7.6 | 8.55 |
EV/Core EBITDA(x) | -12.78 | -12.53 | -39.62 | -25.98 | -13.65 |
Net Sales Growth(%) | 0 | -3.86 | -32.61 | -20.42 | 1.26 |
EBIT Growth(%) | 0 | -1240.68 | 90.65 | -79.33 | -612.5 |
PAT Growth(%) | 0 | -1252.99 | 90.32 | -1511.5 | -79.9 |
EPS Growth(%) | 0 | -720.92 | 90.52 | -1511.35 | -79.9 |
Debt/Equity(x) | -0.38 | -0.46 | -0.45 | -1.27 | -1.05 |
Current Ratio(x) | 0.22 | 0.28 | 0.26 | 0.87 | 0.52 |
Quick Ratio(x) | 0.19 | 0.25 | 0.23 | 0.68 | 0.45 |
Interest Cover(x) | 110.14 | -633.85 | -27.3 | -0.12 | -0.74 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 48.69 | 48.69 | 48.69 | 48.69 | 48.69 | 48.69 | 21.45 | 21.45 | 21.45 | 21.45 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 14.54 | 14.54 | 14.54 | 14.54 | 14.54 | 14.54 | 22.26 | 22.26 | 22.26 | 22.26 |
Public | 36.77 | 36.77 | 36.77 | 36.77 | 36.77 | 36.77 | 56.29 | 56.29 | 56.29 | 56.29 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.27 | 0.27 | 0.27 | 0.27 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 |
Public | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.91 | 1.91 | 1.91 | 1.91 | 1.91 | 1.91 | 1.25 | 1.25 | 1.25 | 1.25 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About